Literature DB >> 26064358

Association of rs5368 and rs3917406 polymorphisms in E-selectin gene with premature coronary artery disease in Chinese Han population.

Hongwei Shan1, Min Zhang1, Mingduo Zhang1, Xin Liu1, Xiantao Song1, Xunli Yin2, Shuzheng Lv1.   

Abstract

OBJECTIVES: Genetics polymorphism of the E-selectin affects the pathogenesis of atherosclerosis and associated with coronary artery disease (CAD). We aimed to investigate the association between the rs5368 and rs3917406 polymorphisms in E-selectin genes and premature CAD (PCAD) in Chinese Han population.
METHODS: PCAD 628 patients and 732 controls were included in the study. E-selectin of rs5368 and rs3917406 polymorphisms were analyzed by polymerase chain reaction (PCR).
RESULTS: The frequencies of T allele of the rs5368 and rs3917406 polymorphisms were 27.2% and 47.8%, respectively, in the PCAD group, and 30.5% and 42.8% in the control group. The frequency of the T allele of the rs3917406 polymorphism was significantly higher in the PCAD group than in the control group (x(2) = 6.857, P = 0.009). In contrast, no statistically significant difference was found between controls and patients in the frequency of T allele of the rs5368 polymorphism. The univariate analysis showed that the E-selectin rs3917406 polymorphisms was associated with the PCAD in additive model (OR = 1.226, 95% CI = 1.05-1.43, P = 0.010) and dominant model (OR = 1.406, 95% CI = 1.11-1.78, P = 0.005). After adjusting for potential confounding variables the rs3917406 polymorphisms was independently associated with PCAD in additive model (OR = 1.347, 95% CI = 1.12-1.62, P = 0.002) and dominant model (OR = 1.669, 95% CI = 1.26-2.21, P < 0.001). The E-selectin rs5368 polymorphisms were not associated with PCAD in univariate and multivariate analyses of three models.
CONCLUSION: Among the Chinese Han population, the rs3917406 polymorphism of the E-selectin gene was associated with PCAD in univariate and multivariate analysis, however, no significant correlation between the E-selectin rs5368 polymorphism and PCAD.

Entities:  

Keywords:  E-selectin; gene polymorphism; premature coronary artery disease

Year:  2015        PMID: 26064358      PMCID: PMC4443192     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

Review 1.  Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies.

Authors:  F Andreotti; I Porto; F Crea; A Maseri
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

Review 2.  Vascular adhesion molecules in atherosclerosis.

Authors:  Elena Galkina; Klaus Ley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-02       Impact factor: 8.311

3.  [Association of C602A and T1559C polymorphisms of E-selectin gene and essential hypertension].

Authors:  Zuo-Guang Wang; Qiu-Li Niu; Wei Gu; Kuo Liu; Yu-Qing Lou; Ya Liu; Jie-Lin Liu; Jie Wen; Shao-Jun Wen; Zhao-Su Wu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2011-05-17

4.  Polymorphism in the human E-selectin gene detected by PCR-SSCP.

Authors:  K Wenzel; R Hanke; A Speer
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

Review 5.  Circulating adhesion molecules in disease.

Authors:  A J Gearing; W Newman
Journal:  Immunol Today       Date:  1993-10

6.  Ascochlorin suppresses oxLDL-induced MMP-9 expression by inhibiting the MEK/ERK signaling pathway in human THP-1 macrophages.

Authors:  Jeong Han Kang; June-Ki Kim; Won-Hwan Park; Kwan-Kyu Park; Tae-Sung Lee; Junji Magae; Hiroo Nakajima; Cheorl-Ho Kim; Young-Chae Chang
Journal:  J Cell Biochem       Date:  2007-10-01       Impact factor: 4.429

7.  Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.

Authors:  Y Inokubo; H Hanada; H Ishizaka; T Fukushi; T Kamada; K Okumura
Journal:  Am Heart J       Date:  2001-02       Impact factor: 4.749

8.  Association between the Ser128Arg variant of the E-selectin and risk of coronary artery disease in the central China.

Authors:  Yan Li; Ye-Sheng Wei; Ming Wang; Ping-An Zhang; Xue-Jun Jiang; Cong-Xin Huang
Journal:  Int J Cardiol       Date:  2004-12-16       Impact factor: 4.164

Review 9.  Adhesion molecules and atherosclerosis.

Authors:  Stefan Blankenberg; Sandrine Barbaux; Laurence Tiret
Journal:  Atherosclerosis       Date:  2003-10       Impact factor: 5.162

10.  Association of SELE genotypes/haplotypes with sE-selectin levels in Taiwanese individuals: interactive effect of MMP9 level.

Authors:  Semon Wu; Lung-An Hsu; Ming-Sheng Teng; Jeng-Feng Lin; Hsien-Hsun Chang; Yu-Chen Sun; Hsuan-Pu Chen; Yu-Lin Ko
Journal:  BMC Med Genet       Date:  2012-11-29       Impact factor: 2.103

View more
  4 in total

1.  Association study between polymorphisms in MIA3, SELE, SMAD3 and CETP genes and coronary artery disease in an Iranian population.

Authors:  Sima Rayat; Nasim Ramezanidoraki; Nima Kazemi; Mohammad H Modarressi; Masoumeh Falah; Safoura Zardadi; Saeid Morovvati
Journal:  BMC Cardiovasc Disord       Date:  2022-06-30       Impact factor: 2.174

2.  E-selectin gene haplotypes are associated with the risk of myocardial infarction.

Authors:  Jarosław Gorący; Mariusz Kaczmarczyk; Andrzej Ciechanowicz; Krzysztof Safranow; Joanna Gorący; Katarzyna Jakubowska; Dariusz Chlubek; Iwona Gorący
Journal:  Arch Med Sci       Date:  2019-04-09       Impact factor: 3.318

3.  Research on the distribution spectrum of atherosclerotic plaques in patients with suspected coronary artery disease and the noninvasive screening model for coronary atherosclerosis burden.

Authors:  Pengxi Han; Jinyan Tang; Ximing Wang; Yuwen Su; Guijie Li; Kai Deng
Journal:  Quant Imaging Med Surg       Date:  2021-07

4.  Comparison of biomarkers of endothelial dysfunction and microvascular endothelial function in patients with primary aldosteronism and essential hypertension.

Authors:  Miaomiao Sang; Yu Fu; Chenmin Wei; Jing Yang; Xueting Qiu; Jingqing Ma; Chao Qin; Feiyan Wu; Xueling Zhou; Tao Yang; Min Sun
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021 Jan-Dec       Impact factor: 1.636

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.